home / stock / lexx / lexx short
Short Information | Lexaria Bioscience Corp. (NASDAQ:LEXX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 637,002 |
Total Actual Volume | 3,144,915 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 31,850 |
Average Short Percentage | 20.80% |
Is there a LEXX Short Squeeze or Breakout about to happen?
See the LEXX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $2.74 | $2.62 | $2.74 | $2.55 | 123,286 | 3,769 | 3.06% |
07-01-2024 | $2.75 | $2.76 | $2.813 | $2.65 | 69,336 | 11,010 | 15.88% |
06-28-2024 | $2.65 | $2.78 | $2.8297 | $2.5779 | 101,127 | 19,516 | 19.3% |
06-27-2024 | $2.69 | $2.63 | $2.84 | $2.52 | 175,656 | 37,375 | 21.28% |
06-26-2024 | $2.58 | $2.61 | $2.652 | $2.5 | 133,652 | 39,260 | 29.37% |
06-25-2024 | $2.83 | $2.59 | $2.83 | $2.5 | 170,783 | 31,346 | 18.35% |
06-24-2024 | $2.57 | $2.65 | $2.83 | $2.57 | 121,062 | 35,317 | 29.17% |
06-21-2024 | $2.9 | $2.69 | $2.9 | $2.66 | 159,784 | 20,853 | 13.05% |
06-20-2024 | $3 | $2.88 | $3.08 | $2.75 | 196,017 | 35,699 | 18.21% |
06-18-2024 | $2.92 | $2.97 | $3.1 | $2.89 | 171,420 | 28,366 | 16.55% |
06-17-2024 | $3.11 | $2.93 | $3.1724 | $2.76 | 255,030 | 63,643 | 24.96% |
06-14-2024 | $3.31 | $3.09 | $3.35 | $2.99 | 97,177 | 10,141 | 10.44% |
06-13-2024 | $3.28 | $3.29 | $3.63 | $3.26 | 151,635 | 26,730 | 17.63% |
06-12-2024 | $3.24 | $3.24 | $3.27 | $3.1 | 75,164 | 23,313 | 31.02% |
06-11-2024 | $3.27 | $3.07 | $3.29 | $3.05 | 82,905 | 29,719 | 35.85% |
06-10-2024 | $3.3 | $3.27 | $3.35 | $3.1306 | 112,554 | 28,404 | 25.24% |
06-07-2024 | $3.41 | $3.27 | $3.74 | $3.18 | 355,893 | 53,674 | 15.08% |
06-06-2024 | $3.7 | $3.41 | $3.84 | $3.2701 | 296,580 | 70,514 | 23.78% |
06-05-2024 | $3.96 | $3.81 | $4.11 | $3.74 | 171,010 | 31,983 | 18.7% |
06-04-2024 | $3.9 | $4 | $4.18 | $3.89 | 124,844 | 36,370 | 29.13% |
News, Short Squeeze, Breakout and More Instantly...
Lexaria Bioscience Corp. Company Name:
LEXX Stock Symbol:
NASDAQ Market:
Lexaria Bioscience Corp. Website:
Lexaria Bioscience Corp. (NASDAQ: LEXX) , a global innovator in drug delivery platforms, is doubling down on glucagon-like peptide 1 (“GLP-1”) studies for the 2024 calendar year. “The company is optimistic that the studies will yield positive results, not just in the potentia...
Lexaria, a global innovator in drug delivery platforms, has announced the successful completion of its second round of dosing for its human pilot study #2 The final study arm is set for completion in early July, and if successful, it will help remedy the downsides of swallowed administration ...
Lexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global innovator in drug delivery platforms, today announced it has hired a contract research organization (“CRO”) to oversee execution of the company’s 12-week chronic study GLP-1-H24-4. The study will evaluate various DehydraTECH...